OpenVSafe by OpenVAERS
Search V-safe

HG7-28054-18509

3 vaccinations 4 coded responses 28 check-ins 3 free-text entries 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
141 / NY
Registered
2022-06-28
Relationship
Child or adolescent in my care
Guardian
2QW-27511-24310
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-24
    Dose 1 — Pfizer-BioNTech
  2. 2022-06-28
    Registered in v-safe
  3. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2022-06-29
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  5. 2022-06-30
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2022-07-01
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-07-08
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  8. 2022-07-15
    Dose 2 — Pfizer-BioNTech
  9. 2022-07-15
    Health check-in — day 0, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2022-07-16
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2022-07-17
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Redness · None
    Adult check-in
  12. 2022-07-18
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  13. 2022-07-20
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  14. 2022-07-21
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2022-07-22
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  16. 2022-07-29
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  17. 2022-08-05
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  18. 2022-08-12
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  19. 2022-08-19
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  20. 2022-08-26
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  21. 2022-09-09
    Dose 3 — Pfizer-BioNTech
  22. 2022-09-10
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness
    Free text: Decrease in appetite
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-09-11
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Nasal congestion, Oropharyngeal pain, Rhinorrhoea, Throat irritation — Feeling: Poor · Fatigue or tiredness · Be unable to work or attend school
    Free text: Stuffy/runny nose and sore/itchy throat
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-09-14
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  25. 2022-09-16
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  26. 2022-09-23
    Survey response — day 14, dose 3, dependent
    MedDRA: Cough, Malaise, Nasal congestion, Office visit, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: His runny nose that started on 9/12 turned in to congestion, cough, and fever since 9/20 · Healthcare visit (other): In office pediatrician sick visit
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-09-23
    Report sent to call center — day 14, dose 3, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  28. 2022-09-26
  29. 2022-09-30
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  30. 2022-10-07
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  31. 2022-10-14
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  32. 2022-10-21
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  33. 2022-12-09
  34. 2023-03-10
    Survey response — 6 months, dose 3, dependent
    MedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-06-24Pfizer-BioNTech No
22022-07-15Pfizer-BioNTech No
32022-09-09Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 — days 1–6 daily, dose 3, dependent

2022-09-10

Systemic reaction (other): Decrease in appetite

2022-09-11

Systemic reaction (other): Stuffy/runny nose and sore/itchy throat

Release 12 — day 14, dose 3, dependent

2022-09-23

Symptoms: His runny nose that started on 9/12 turned in to congestion, cough, and fever since 9/20
Healthcare visit (other): In office pediatrician sick visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMalaise · · ✓
HCVOOffice visit · · ✓
SDCough · · ✓
SDNasal congestion · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SRODecreased appetite · · ✓
SRONasal congestion · · ✓
SROOropharyngeal pain · · ✓
SRORhinorrhoea · · ✓
SROThroat irritation · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release